NASHVILLE, Tenn., July 31, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2025.
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time
PHOENIX, July 31, 2025 /PRNewswire/ -- SenesTech, Inc....
EDINBURG, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced second quarter 2025 financial and operating results.
Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP
Coveo reports...
Growth rate reaccelerates to 16% for the Coveo core platform(2)Generative AI solutions drove ~50% of new business during the quarterBroadens relationship with SAP
Coveo reports...
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it will release its financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 after market close.
Samsung arbitration decision and new HP license agreement drive Q2 results, exceeding outlook Annualized recurring revenue1, at all-time high of $553 million, up 44% YoY Company raises full year 2025 revenue guidance by $110 million
Total revenue in the quarter of $304.9 million grew 15% year-over-year and exceeded outlook
Gross margin improved to 42%, with gross profit increasing 19% year-over-year exceeding...
LUNEL, France, July 31, 2025 /CNW/ - Foraco International SA (TSX: FAR) ("Foraco" or the "Company"), a leading global provider of drilling services, announces...
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.